Antiepileptic drugs--protein binding and interaction
Johannessen, S.I.; Strandjord, R.E.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 94(29): 2019-2021
1974
ISSN/ISBN: 0029-2001 PMID: 4421142 Document Number: 73566
Document emailed within 1 workday
Related Documents
Pacifici, G.M.; Viani, A.; Rizzo, G.; Carrai, M. 1989: Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs International Journal of Clinical Pharmacology Therapy and Toxicology 27(7): 362-365Kaneo, Y.; Sento, C.; Kinoshita, R.; Kato, Y. 1981: Protein binding of non-steroidal anti-inflammatory drugs. V. Effects of various drugs on the binding of naproxen to bovine serum albumin Acta Pharmaceutica Suecica 18(1): 45-54
Shorvon, S.D.; Tallis, R.C.; Wallace, H.K. 2002: Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice Journal of Neurology Neurosurgery and Psychiatry 72(1): 114-115
Connelly, P.R. 1991: Thermodynamics of interaction of FK 506-binding protein and its ligands Transplantation Proceedings 23(6): 2883-2885
Stepanenko, O.'g.V.; Povarova, O.I.; Fonin, A.V.; Stepanenko, O.V. 2010: Stability of sugar-binding proteins: D-galactose/D-glucose-binding protein from Escherichia coli and trehalose/maltose-binding protein from Thermococcus litoralis Tsitologiia 52(11): 950-954
Sokolenko, A.A.; Sedova, V.M.; Tulokhonov, I.I.; Savinkova, L.K. 1997: Analysis of interaction of human RNA-polymerase Ii and TATA-binding protein Molekuliarnaia Biologiia 31(6): 962-965
Lecchini, S.; Gatti, G.; De Bernardi, M.; Caravaggi, M.; Frigo, G.M.; Calzetti, S.; Visintini, D. 1978: Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate Il Farmaco; Edizione Pratica 33(2): 80-82
Gollnick, P.; Baumann, C.; Yang, M.; Otridge, J.; Antson, A. 1995: Interaction of the 11-subunit trp RNA-binding attenuation protein (TRAP) with its RNA target Nucleic Acids Symposium Series 33: 43-45
Yu, H.Y.; Shen, Y.Z. 1982: Serum protein binding interaction between valproic acid and phenobarbital in vitro Journal of the Formosan Medical Association 81(12): 1482-1491
Kassenbrock, C.K.; Kelly, R.B. 1989: Interaction of heavy chain binding protein (BiP/GRP78) with adenine nucleotides EMBO Journal 8(5): 1461-1467
Li, F.; Guo, X.; Qiao, M.; Xiong, Z.; Zhou, D. 2004: Evaluation of drug interaction in binding to protein by high performance liquid chromatography Se Pu 22(4): 349-353
Elferink, F.; van der Vijgh, W.J.; Klein, I.; Pinedo, H.M. 1986: Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding Clinical Chemistry 32(4): 641-645
Ninni, A.; Sarappa, A.; D'Antonio, G.; Scognamiglio, S. 1978: Protein binding and action mechanism of drugs Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 33(3): 164-173
Onaran, H.O.; Costa, T.; Rodbard, D. 1993: Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits Molecular Pharmacology 43(2): 245-256
Bevilacqua, R.; Benassi, C.A.; Schiavon, O.; Veronese, F.M. 1981: Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs Il Farmaco; Edizione Scientifica 36(7): 598-605
McLeish, K.R.; Gierschik, P.; Jakobs, K.H. 1989: Desensitization uncouples the formyl peptide receptor-guanine nucleotide-binding protein interaction in HL60 cells Molecular Pharmacology 36(3): 384-390
Podder, S.K.; Dasgupta, D. 1980: Specificity in protein-nucleic acid interaction: Part II--Binding of mono- and di-nucleoside phosphate to poly-L-lysine at different conformations Indian Journal of Biochemistry and Biophysics 17(5): 357-360
Belpaire, F. 1987: Effect of inflammation on blood protein binding, pharmacokinetics and pharmacodynamics of drugs Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 49(1): 83-97
Wong, I.C. 1997: New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years Bmj 314(7080): 603-604
von Zabern, I.; Bloom, E.L.; Chu, V.; Gigli, I. 1982: The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator Journal of Immunology 128(3): 1433-1438